Details for: MULTI-12/K1 PEDIATRIC
Product description
Product name: MULTI-12/K1 PEDIATRIC
Company name: SANDOZ CANADA INCORPORATED
DIN: 02242529
Status: Marketed
Status date: 2006-07-06
Active ingredient(s) | Strength |
---|---|
ASCORBIC ACID (ASCORBIC ACID) | 80 MG / VIAL |
BIOTIN | 20 MCG / VIAL |
DEXPANTHENOL | 5 MG / VIAL |
FOLIC ACID | 140 MCG / VIAL |
NICOTINAMIDE | 17 MG / VIAL |
PYRIDOXINE HYDROCHLORIDE | 1 MG / VIAL |
VITAMIN A | 2300 UNIT / VIAL |
VITAMIN B12 (CYANOCOBALAMIN) | 1 MCG / VIAL |
VITAMIN B1 (THIAMINE HYDROCHLORIDE) | 1.2 MG / VIAL |
VITAMIN B2 (RIBOFLAVIN-5-PHOSPHATE) | 1.4 MG / VIAL |
VITAMIN D | 400 UNIT / VIAL |
VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) | 7 UNIT / VIAL |
VITAMIN K1 | 0.2 MG / VIAL |
Resources
Click on a resource to visit a page with more information. You may be taken away from this page to a different Government of Canada website.
For consumers
Resource | Description |
---|---|
Report a side effect |
Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are:
|
For health care professionals
Resource | Description |
---|---|
Report a serious adverse drug reaction (for hospitals) |
Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals. |
For researchers
Resource | Description |
---|---|
Search Clinical Information | After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes. |
All resources
Resource | Description |
---|---|
Search Clinical Information | After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes. |
Report a side effect |
Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are:
|
Report a serious adverse drug reaction (for hospitals) |
Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals. |
Resource | Description |
---|---|
Report a side effect |
Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are:
|